SCHEMBL12390331

SCHEMBL12390331

Cc1ccc(Cn2c(-c3ccc(Br)s3)cc(C(F)(F)F)c(C#N)c2=O)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 3/20 0.50
NR1H2 P55055 3/20 0.50
NR1H3 Q13133 3/20 0.50
ALDH1A1 P00352 8/20 0.40
KDM4E B2RXH2 6/20 0.40
HSD17B10 Q99714 3/20 0.40
HPGD P15428 6/20 0.39
GLA P06280 3/20 0.39
GAA P10253 3/20 0.39
ATM Q13315 1/20 0.39
PDE9A O76083 1/20 0.36
PDE1C Q14123 1/20 0.36
NPSR1 Q6W5P4 2/20 0.35
PPARG P37231 1/20 0.35
NCOA2 Q15596 1/20 0.35
NCOA1 Q15788 1/20 0.35
RXFP1 Q9HBX9 1/20 0.35
NCOA3 Q9Y6Q9 1/20 0.35
TP53 P04637 1/20 0.34
MAPT P10636 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12389545 0.89 RXRA (0.53) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL4899614 0.87 NR1H2 (0.52) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL12390329 0.86 RXRA (0.58) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL12390445 0.85 RXRA (0.57) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL14944219 0.84 RXRA (0.55) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL12366985 0.83 RXRA (0.35) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL2263602 0.82 RXRA (0.52) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL4907677 0.81 RXRA (0.49) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL2386420 0.80 RXRA (0.67) RXRANR1H2NR1H3ALDH1A1KDM4E
SCHEMBL2265833 0.80 KDM4E (0.55) RXRANR1H2NR1H3ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998986-B2 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors EXELIXIS PATENT COMPANY LLC (US) 2011-08-16 US disclosed